Abbott Laboratories
Market cap $190.4B
$109.93
ABT
$109.93
-3.23% today
Buy with €1M virtual cash · No real money
Abbott Laboratories (ABT) is a publicly traded company listed on the XNYS. As of November 8, 2026, Invest's signal rates ABT a Hold, with the stock down 12% over the past year. You can practice trading ABT risk-free with €1,000,000 in virtual cash.
Key stats
As of November 8, 2026
Market Cap
$190.4B
Volume
8.3M
52-wk High
$132.03
52-wk Low
$81.97
Day High
$111.81
Day Low
$109.81
Performance
1M
+11.6%
6M
+30.4%
1Y
-11.7%
Invest signal · ABT
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
ABT overview
AI overviewAbout Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Employees
115,000
How to practice trading ABT
- 1
Use the ABT buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top ABT traders on Invest
Full leaderboardFrequently asked questions
Is ABT a good stock to buy right now?
As of November 8, 2026, Invest's signal rates ABT a Hold, based on its price trend, valuation, and fundamentals, with the stock down 12% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading ABT risk-free first.
What is Abbott Laboratories's (ABT) market cap?
Abbott Laboratories has a market capitalization of approximately $190.4B.
How has ABT stock performed?
ABT is down 12% over the past year and up 30% over six months. Its 52-week range runs roughly from $81.97 to $132.03. Past performance doesn't predict future results.
How can I practice trading ABT for free?
On Invest you get €1,000,000 in virtual cash and can buy ABT at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare ABT with peers